Pliant and Acelyrin adopt poison pill measures to counter activist investor Kevin Tang's stock accumulation, aiming to ...

The move by Acelyrin’s board comes as the venture capital firm has taken larger and larger stakes in the company in an ...

The late-stage biopharma said the plan will issue one right for each share of common stock as of the close of business on March 24. The rights will initially trade with its common stock, and will ...

Acelyrin and Pliant Therapeutics, both of which are viewed as takeover targets for Kevin Tang’s Concentra Biosciences, each adopted a “poison pill” on Thursday morning.

House Republicans are hoping to vote Tuesday on a stopgap bill aimed at funding the federal government through September 30 ...

QXO on Tuesday once again extended the deadline for its $11 billion takeover offer for Beacon Roofing Supply by a week to ...

The mechanism, known as a "poison pill," was approved by a majority of Hapvida shareholders in a general meeting on Tuesday, according to the meeting minutes. Sign up here. British insurer Beazley ...

Target companies can use certain defenses, such as a poison pill or a golden parachute, to ward off hostile takeovers. Investopedia / Matthew Collins A hostile takeover allows the new majority ...

Acelyrin (NASDAQ:SLRN) announced Thursday a decision to adopt a limited-duration stockholder rights plan, also known as a poison pill, after Tang Capital Partners rapidly accumulated 8.8% of the ...